drugset / Trial / NCT01202188
A Study to Assess the Efficacy, Safety and Tolerability of Once-daily (q.d.) QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to provide pivotal efficacy and safety data for QVA149 in patients with moderate to severe COPD.
Timeline
- Start
- 2010-09
- Primary completion
- 2012-02
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Glycopyrronium | Unknown | 50 ug | Inhaled |
| Comparator | Indacaterol | Other / unclassified | 110 ug | Inhaled |
| Comparator | Indacaterol | Other / unclassified | 150 ug | Inhaled |
| Comparator | Tiotropium | Other / unclassified | 18 ug | Inhaled |